ACQUISITION

6 Months Ended

Jun. 30, 2025

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

ACQUISITION

NOTE 13 – ACQUISITION

On October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest in Goldman’s Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $1,780,000.

The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805, Business Combination. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:


Cash	$	1,495
Customer deposits – intercompany		7,360
Domain names [1]		40,310
Raw materials		149,260
Manufacturing equipment		717,020
Total assets acquired	$	915,445

Accounts payable	$	323
Customer deposits		572,386
Total liabilities assumed	$	572,709

Net assets acquired		342,736

Consideration [2]	$	1,207,614
Fair value of noncontrolling interest in ELRT Technologies, LLC		8,823
Total		1,216,437

Goodwill	$	873,701

[1]	Domain names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further discussed in our impairment policy.

[2]	This amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2025

(Unaudited)

Investview, Inc. 10-Q